PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Cardiovascular & Lipidology/LDL-C
Cardiovascular & LipidologyLipid Metabolism & Endothelial Biology

Low-Density Lipoprotein Cholesterol (LDL-C)

LDL-C measures the total mass of cholesterol transported within low-density lipoprotein particles. While clinically ubiquitous, it serves as a surrogate proxy for total atherogenic particle burden.

Standard Range< 100 mg/dL
Optimal Longevity< 70 mg/dL (or < 55 mg/dL in secondary prevention)
Measurement Unitmg/dL
Organ SystemLipid Metabolism & Endothelial Biology
Routine Panels:Lipid PanelComprehensive Metabolic Panel with ReflexCardio IQ®

Standard vs. Optimal Reference Rangesmg/dL

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: mg/dL
mg/dL
Presets:
0 mg/dLOptimal Zone Target135 mg/dL
Optimal Longevity Zone(35 mg/dL)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

< 100 mg/dL

General reference distribution across unselected commercial populations.

Optimal Longevity Target

< 70 mg/dL (or < 55 mg/dL in secondary prevention)

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Circulating LDL particles undergo oxidative modification in the arterial intima. Scavenger receptors on subendothelial macrophages ingest oxidized LDL particles without negative feedback regulation, driving foam cell accumulation and necrotic core expansion within atherosclerotic plaques.

Differential Diagnosis

Elevated Levels (LDL-C High)

  • •Familial hypercholesterolemia (LDLR, APOB, or PCSK9 mutations)
  • •Obstructive biliary disease
  • •Hypothyroidism
  • •Nephrotic syndrome

Low Levels (LDL-C Low)

  • •Primary hypocholesterolemia
  • •Severe malabsorption / Celiac disease
  • •Hyperthyroidism
  • •Cachexia and systemic chronic illness

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the cellular and molecular level, Low-Density Lipoprotein Cholesterol (LDL-C) is central to lipoprotein particle assembly, apolipoprotein-receptor interactions, and subendothelial retention kinetics. Synthesis occurs primarily within hepatocytes and enterocytes, regulated by transcriptional co-activators (such as SREBP-2 and PPAR-alpha) and microsomal triglyceride transfer protein (MTP). Particle clearance is mediated through high-affinity endocytic receptors (including LDLR, LRP1, and scavenger receptors SR-B1). Circulating plasma half-life ranges from 2 to 4 days. Transcytosis across vascular endothelial cell monolayers occurs via scavenger receptor class B type 1 (SR-B1) and activin-like kinase 1 (ALK1), trapping particles within the subendothelial proteoglycan matrix where oxidative modification initiates foam cell formation.
Longevity Risk Architecture & Epidemiology
Cumulative lifetime exposure to circulating LDL cholesterol (expressed in cholesterol-years) correlates directly with atherosclerotic plaque burden and vascular biological age.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Standard testing requires a 10 to 12 hour overnight fast to minimize postprandial chylomicron interference, although LDL-C direct immunoassay is less sensitive to prandial state than calculated LDL-C. Avoid strenuous high-intensity exercise 24 hours prior to blood draw. Serum separator tubes (SST) or EDTA plasma should be centrifuged within 2 hours. High-dose biotin (>5 mg/day) supplementation may interfere with competitive streptavidin-biotin immunoassays, requiring a 48-hour washout period.

Reflexive Testing Protocol:

  • Advanced Lipoprotein Particle Quantification (NMR spectroscopy or ion mobility LDL-P)
  • Lipoprotein(a) [Lp(a)] baseline evaluation for genetic cardiovascular risk stratification
  • Coronary Artery Calcium (CAC) score via non-contrast cardiac CT to evaluate calcified plaque burden
  • High-sensitivity C-Reactive Protein (hs-CRP) to assess systemic vascular inflammatory tone
  • Carotid intima-media thickness (CIMT) duplex ultrasound to assess subclinical atherosclerosis
Clinical Citations & Primary Literature (1)
  • [1]2019 ESC/EAS Guidelines for the management of dyslipidaemias - European Heart Journal (2020). PMID: 31504427
Common Panels:Lipid PanelComprehensive Metabolic Panel with ReflexCardio IQ®
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Low-Density Lipoprotein Cholesterol (LDL-C) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Cardiovascular & Lipidology Biomarkers

Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
High-Density Lipoprotein Cholesterol
HDL-C · 50 - 70 mg/dL
Serum Triglycerides
TG · < 80 mg/dL (Fasting)
High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
PreviousLipoprotein(a) (Lp(a))Cardiovascular & LipidologyNextHigh-Density Lipoprotein Cholesterol (HDL-C)Cardiovascular & Lipidology